1. Home
  2. APLE vs CRNX Comparison

APLE vs CRNX Comparison

Compare APLE & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

APLE

Apple Hospitality REIT Inc.

HOLD

Current Price

$16.55

Market Cap

3.8B

Sector

Real Estate

ML Signal

HOLD

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$35.48

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APLE
CRNX
Founded
2007
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.9B
IPO Year
2007
2018

Fundamental Metrics

Financial Performance
Metric
APLE
CRNX
Price
$16.55
$35.48
Analyst Decision
Buy
Strong Buy
Analyst Count
8
8
Target Price
$13.00
$76.75
AVG Volume (30 Days)
2.3M
850.3K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
7.12%
N/A
EPS Growth
N/A
N/A
EPS
0.12
N/A
Revenue
$1,238,622,000.00
$1,039,000.00
Revenue This Year
$2.31
$720.10
Revenue Next Year
$2.35
$184.67
P/E Ratio
$137.79
N/A
Revenue Growth
18.98
N/A
52 Week Low
$10.85
$25.83
52 Week High
$16.71
$57.99

Technical Indicators

Market Signals
Indicator
APLE
CRNX
Relative Strength Index (RSI) 78.13 51.40
Support Level $11.50 $33.15
Resistance Level N/A $44.89
Average True Range (ATR) 0.34 1.56
MACD 0.04 0.33
Stochastic Oscillator 94.59 79.51

Price Performance

Historical Comparison
APLE
CRNX

About APLE Apple Hospitality REIT Inc.

Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

Share on Social Networks: